
Regeneron, Sanofi Withdraw FDA Application For Cancer Drug’s Expanded Use
Libtayo is an anti-cancer drug developed by Regeneron Pharmaceuticals Inc. and Sanofi for advanced cervical cancer patients. The two companies withdrew their application for expanded